Clinical Trials

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

119 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT07448077 2026-03-04

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC

128 enrolled

Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT02645149 2026-02-27

Match Mel

Phase 2 Completed

216 enrolled

Melanoma

NCT04594187 2026-02-17

MelPORT

168 enrolled

Melanoma

NCT07407166 2026-02-17

Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers

Phase NA Recruiting

40 enrolled

Phase NA Not yet recruiting

Melanoma

NCT07396116 2026-02-12

FUSION-02

28 enrolled

Sarcoma

Radiation Injuries, Sarcoma

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

60 enrolled

Limited Stage Small Cell Lung Cancer

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

19 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT06610734 2026-02-09

SKY

202 enrolled

Small Cell Lung Cancer Extensive Stage

NCT05488626 2026-02-05

ARTIA-Lung

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05978193 2026-01-22

SCR-ESCC-01

100 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04821778 2026-01-21

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

2,000 enrolled

Esophageal Neoplasms

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

2,000 enrolled

Esophageal Neoplasms

NCT04151940 2026-01-14

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Phase NA Recruiting

80 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07337096 2026-01-13

Electro-Acupuncture in Lung cancER : EALER Study

424 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

38 enrolled

Pancreatic Cancer Liver Metastases

NCT06676449 2026-01-07

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

432 enrolled

Esophageal Neoplasms

NCT07259473 2026-01-07

Pre-CATALIS

15 enrolled

Turcot syndrome

NCT05717166 2025-12-31

SABR-SYNC

180 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07040956 2025-12-29

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

98 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07305428 2025-12-26

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

Phase NA Recruiting

30 enrolled

Carcinoma, Hepatocellular

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

164 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07297030 2025-12-22

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

37 enrolled

Rectal Neoplasms

NCT06102057 2025-12-17

PACCELIO

110 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07257497 2025-12-02

Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol

20 enrolled

Other solid neoplasm

Solid Tumor Cancer

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Lung Neoplasms

NCT07254858 2025-11-28

CISN-L

302 enrolled

Breast

Breast Neoplasms

NCT07250542 2025-11-26

A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT04454489 2025-11-19

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Phase 2 Completed

21 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck

NCT06804850 2025-11-19

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Phase 2 Withdrawn

Phase NA Active not recruiting

Head and Neck Neoplasms

NCT06146920 2025-11-18

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

39 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07231575 2025-11-18

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

39 enrolled

Neoadjuvant Immunotherapy

NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Phase NA Completed

45 enrolled 13 charts

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04926948 2025-10-22

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

20 enrolled

Phase 2 Active not recruiting

Pleural Mesothelial Neoplasm

NCT03383094 2025-10-07

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

126 enrolled

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Recurrence

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Phase 1 Completed

21 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT03721341 2025-09-18

SABR-COMET 10

204 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06624644 2025-09-10

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Recruiting

135 enrolled

Melanoma

NCT06831136 2025-09-10

PANCARDINAL-2